Search

everythinglearnresearchcommunity

for

Search:↓

Some side effects of breast cancer chemotherapy, like neuropathy and nail loss, can last long after treatment.

No current patient-reported outcome measure fully meets FDA requirements for alopecia treatments.

Patients with alopecia areata in Saudi Arabia understand the condition's seriousness but still face significant psychological challenges.

PCOS patients, especially obese ones, often lack vitamin D and may need supplements and lifestyle changes.

Educating patients on phototrichogram increased satisfaction in androgenetic alopecia treatment.

Current treatments for Alopecia Areata don't fully meet patients' needs, indicating a need for better therapies.

Alopecia areata greatly harms quality of life, causing emotional and social issues.

Older age and existing health conditions increase COVID-19 death risk.

Stress greatly reduces the quality of life in women with PCOS-related infertility.

Older age and existing health issues increase COVID-19 death risk.

Skin diseases significantly lower the quality of life for patients in southern Brazil, especially for younger, single, and lower-income individuals.

Severe Hidradenitis Suppurativa increases missed and unproductive workdays.

Hair loss severity is linked to depression, not anxiety, in Filipino men, with older, less educated men with more hair loss at higher risk.

Iron supplements improve life quality for people with anemia.

Severe pediatric alopecia areata worsens quality of life for patients and families.

Wearing wigs or hairpieces improves self-esteem, adaptability, and competence in women with alopecia areata.

Hair loss can cause anxiety and depression, especially in young, single women, and early psychological support is important.

Minoxidil improves quality of life for women with hair loss.

Rosiglitazone may be better than metformin for insulin resistance in PCOS, but more research is needed on certain biomarkers.

People respond differently to hair loss treatment with PRP because of individual differences in growth factors from platelets.

Metabolic syndrome reduces effectiveness of hair loss treatment.

Combining barber scalp care with medical treatment improves scalp health and well-being in early-stage alopecia.

Patients and clinicians generally agree on eyebrow and eyelash hair loss improvements in severe alopecia areata.

Topical finasteride/minoxidil is effective but not better than oral finasteride for hair loss.

The HAIR-Q is a reliable tool for assessing patient satisfaction with hair loss treatments.

The cream effectively treats scalp psoriasis, improving symptoms and quality of life, with high patient satisfaction.

The Hair Check tool can measure hair loss, but patients' own reports are more reliable for assessing hair loss during chemotherapy.

Neoadjuvant endocrine therapy led to a better future outlook than chemotherapy, with no major quality of life differences.

Reporter characteristics affect detection of hair loss from cancer therapy.

Gender-affirming hormone treatments need better patient-focused outcome measurements and standardized data collection.